Global Energy based Ablation Devices Industry

Global Energy based Ablation Devices Industry

  • July 2020 •
  • 456 pages •
  • Report ID: 5443632 •
  • Format: PDF
Global Energy based Ablation Devices Market to Reach $9.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Energy based Ablation Devices estimated at US$4.6 Billion in the year 2020, is projected to reach a revised size of US$9.2 Billion by 2027, growing at a CAGR of 10.3% over the analysis period 2020-2027. Radiation, one of the segments analyzed in the report, is projected to record a 9.6% CAGR and reach US$3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Radiofrequency segment is readjusted to a revised 11.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow at 13.5% CAGR

The Energy based Ablation Devices market in the U.S. is estimated at US$1.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2027 trailing a CAGR of 13.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.2% and 8.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8% CAGR.

Ultrasound Segment to Record 10.9% CAGR

In the global Ultrasound segment, USA, Canada, Japan, China and Europe will drive the 10.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$451.9 Million in the year 2020 will reach a projected size of US$891.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.3 Billion by the year 2027, while Latin America will expand at a 12.4% CAGR through the analysis period. We bring years of research experience to this 16th edition of our report. The 456-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,
  • AngioDynamics Inc.
  • AtriCure Inc.
  • BIOLASE Inc.
  • biolitec AG
  • Biosense Webster, Inc.
  • Boston Scientific Corporation
  • EDAP TMS S.A.
  • Ethicon Endo-Surgery Inc.
  • Halyard Health Inc.
  • InSightec® Ltd.
  • Medtronic Inc.
  • Monteris Medical Inc.
  • Olympus America Inc.
  • Photocure ASA
  • PhotoMedex Inc.
  • Sichuan Jinjiang Electronic Science and Technology Co. Ltd.
  • Smith & Nephew Plc
  • Stryker Corporation
  • Syneron & Candela
  • Varian Medical Systems